Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients

Luka Verrest(The Netherlands Cancer Institute), Thomas P. C. Dorlo(Uppsala University), Alwin D. R. Huitema(The Netherlands Cancer Institute), Yalemtsehay Mekonnen(Addis Ababa University), Mahmoud M. E. Mudawi(Northern Border University), Eyasu Makonnen(Karolinska Institutet), Rashid Aman(King Abdullah University of Science and Technology), Zewdu Hurissa(Asossa University), Workagegnehu Hailu(University of Gondar), Jaya Chakravarty(Institute of Medical Sciences), Jos H. Beijnen(The Netherlands Cancer Institute), Monique Wasunna(Kenya AIDS Vaccine Initiative), Fabiana Alves(Drugs for Neglected Diseases Initiative), Gilbert Kokwaro(Strathmore University), Samson Tesfaye(Addis Ababa University), Ahmed Musa(University of Khartoum), Madhukar Rai(Institute of Medical Sciences), Brima M. Younis(University of Khartoum), Asrat Hailu(Addis Ababa University), Eltahir Awad Gasim Khalil(University of Khartoum), Smita Kshirsagar(Stanford Medicine), Shyam Sundar(Institute of Medical Sciences)
Clinical Pharmacokinetics
June 9, 2021
Cited by 13


Related Papers